MWNA
ABMD

Marshall Wace North America’s Abiomed Inc ABMD Stock Holding History

Marshall Wace North America’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$868K Buy
+2,667
New +$903K ﹤0.01% 972
2021
Q2 		– Sell
-3,220
Closed -$1.03M – 1914
2021
Q1 		$1.03M Sell
3,220
-3,882
-55% -$1.24M ﹤0.01% 1030
2020
Q4 		$2.3M Sell
7,102
-738
-9% -$204K 0.01% 719
2020
Q3 		$2.17M Sell
7,840
-1,939
-20% -$559K 0.01% 562
2020
Q2 		$2.36M Buy
+9,779
New +$1.96M 0.02% 540
2019
Q4 		– Sell
-685
Closed -$122K – 1701
2019
Q3 		$122K Sell
685
-4,105
-86% -$887K ﹤0.01% 1027
2019
Q2 		$1.25M Sell
4,790
-185,720
-97% -$49.3M 0.01% 690
2019
Q1 		$54.4M Buy
190,510
+11,194
+6% +$3.72M 0.39% 78
2018
Q4 		$58.3M Sell
179,316
-510,844
-74% -$177M 0.56% 48
2018
Q3 		$310M Buy
690,160
+214,655
+45% +$84.6M 2.13% 3
2018
Q2 		$195M Sell
475,505
-61,737
-11% -$22.4M 1.1% 10
2018
Q1 		$156M Buy
537,242
+59,624
+12% +$15.1M 0.78% 17
2017
Q4 		$89.5M Buy
477,618
+346,758
+265% +$64.7M 0.49% 38
2017
Q3 		$22.1M Buy
130,860
+127,296
+3,572% +$19.2M 0.14% 199
2017
Q2 		$510K Sell
3,564
-74,642
-95% -$10M ﹤0.01% 1087
2017
Q1 		$9.78M Buy
+78,206
New +$9.07M 0.08% 274
2013
Q4 		– Sell
-73,810
Closed -$1.41M – 872
2013
Q3 		$1.41M Buy
+73,810
New +$1.69M 0.04% 305

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Marshall Wace North America's ABMD Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Abiomed Inc (ABMD) in Q3 2021: 2,667 shares worth $868K. The stake represents ﹤0.01% of the portfolio and ranks #972 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in ABMD as recently as Q1 2021.

Marshall Wace North America first reported a position in ABMD in Q3 2013 and has held it in 17 quarters since. The position peaked at $310M in Q3 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

  • Marshall Wace North America held 2,667 shares of Abiomed Inc worth $868K as of Q3 2021.
  • Abiomed Inc was a new Marshall Wace North America position in Q3 2021.
  • Abiomed Inc made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #972 holding.
  • Marshall Wace North America first reported a position in Abiomed Inc in Q3 2013 and has held it in 17 quarters since.
  • Marshall Wace North America's Abiomed Inc position peaked at $310M in Q3 2018.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.